Global prevalence of eligibility for biologic therapy in ATS/ERS-defined severe asthma: A systematic review. [PDF]
Yang F +4 more
europepmc +1 more source
Optimizing Biologic Treatment Selection in Chronic Rhinosinusitis with Nasal Polyps: A Network Meta-Analysis of Efficacy and Safety Across 22 RCTs. [PDF]
Safia A +4 more
europepmc +1 more source
Persistent airway obstruction in severe eosinophilic asthma: targeting interleukin-5 and eosinophils. [PDF]
Hanania NA, Herth FJF.
europepmc +1 more source
Population Pharmacokinetics and Exposure-Response Analysis of Benralizumab in Chinese Adults, Adolescents, and Pediatric Participants with Severe Eosinophilic Asthma. [PDF]
Jin Y +9 more
europepmc +1 more source
Monoclonal antibodies in severe asthma: outcomes from real-world data. [PDF]
Del-Barrio-Buesa S +13 more
europepmc +1 more source
Paradoxical Use of Benralizumab in Reactive Hypereosinophilia from Toxocariasis and Tuberculosis Co-Infection-Case Report and Literature Review. [PDF]
Bertici NS +4 more
europepmc +1 more source
Comparative efficacy of biologics for uncontrolled asthma patients with chronic rhinosinusitis or nasal polyps: a systematic review and network meta-analysis. [PDF]
Tsukada A +7 more
europepmc +1 more source
The Comparative Effectiveness of Mepolizumab and Benralizumab in the Treatment of Eosinophilic Asthma. [PDF]
Niemiec-Górska A +6 more
europepmc +1 more source

